A double blind, randomized trial of sertraline for alcohol dependence Moderation by age of onset and 5-hydroxytryptamine transporter linked promoter region genotype / Henry R. Kranzler en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 1 (Febrero) . - pp. 22-30 Título : A double blind, randomized trial of sertraline for alcohol dependence Moderation by age of onset and 5-hydroxytryptamine transporter linked promoter region genotype Tipo de documento: texto impreso Autores: Henry R. Kranzler, Autor ; Stephen Armeli, Autor ; Howard Tennen, Autor Fecha de publicación: 2022 Artículo en la página: pp. 22-30 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: ISRS, Edad de inicio, Dependencia alcohólica, 5-HTTLPR, Farmacogenética, Respuesta al tratamiento Resumen: Late-onset/low-vulnerability alcoholics (LOAs) appear to drink less when treated with a selective serotonin reuptake inhibitor than placebo, whereas early-onset/high-vulnerability alcoholics (EOAs) show the opposite effect. We conducted a 12-week, parallel-group, placebo-controlled trial of the efficacy of sertraline in alcohol dependence (AD). Link: ./index.php?lvl=notice_display&id=29404 [artículo] A double blind, randomized trial of sertraline for alcohol dependence Moderation by age of onset and 5-hydroxytryptamine transporter linked promoter region genotype [texto impreso] / Henry R. Kranzler, Autor ; Stephen Armeli, Autor ; Howard Tennen, Autor . - 2022 . - pp. 22-30. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 1 (Febrero) . - pp. 22-30 Palabras clave: ISRS, Edad de inicio, Dependencia alcohólica, 5-HTTLPR, Farmacogenética, Respuesta al tratamiento Resumen: Late-onset/low-vulnerability alcoholics (LOAs) appear to drink less when treated with a selective serotonin reuptake inhibitor than placebo, whereas early-onset/high-vulnerability alcoholics (EOAs) show the opposite effect. We conducted a 12-week, parallel-group, placebo-controlled trial of the efficacy of sertraline in alcohol dependence (AD). Link: ./index.php?lvl=notice_display&id=29404

Targeted naltrexone for early problem drinkers / Henry R. Kranzler en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 3 (Junio) . - pp. 294-304 Título : Targeted naltrexone for early problem drinkers Tipo de documento: texto impreso Autores: Henry R. Kranzler, Autor ; Stephen Armeli, Autor ; Howard Tennen, Autor Fecha de publicación: 2023 Artículo en la página: pp. 294-304 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Consumo de alcohol, Naltrexona - uso terapéutico Resumen: Most published studies of the efficacy of naltrexone for alcohol treatment have focused on daily medication for relapse prevention among abstinent alcoholics. The present study compared the effects of naltrexone with those of placebo in a sample of early problem drinkers who received study medication either daily or targeted to situations identified by the patients as being high risk for heavy drinking. Link: ./index.php?lvl=notice_display&id=31025 [artículo] Targeted naltrexone for early problem drinkers [texto impreso] / Henry R. Kranzler, Autor ; Stephen Armeli, Autor ; Howard Tennen, Autor . - 2023 . - pp. 294-304. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 3 (Junio) . - pp. 294-304 Palabras clave: Consumo de alcohol, Naltrexona - uso terapéutico Resumen: Most published studies of the efficacy of naltrexone for alcohol treatment have focused on daily medication for relapse prevention among abstinent alcoholics. The present study compared the effects of naltrexone with those of placebo in a sample of early problem drinkers who received study medication either daily or targeted to situations identified by the patients as being high risk for heavy drinking. Link: ./index.php?lvl=notice_display&id=31025

Targeted naltrexone for problem drinkers / Henry R. Kranzler en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 4 (Agosto) . - pp. 350-357 Título : Targeted naltrexone for problem drinkers Tipo de documento: texto impreso Autores: Henry R. Kranzler, Autor ; Howard Tennen, Autor ; Stephen Armeli, Autor Fecha de publicación: 2022 Artículo en la página: pp. 350-357 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Naltrexona, Farmacoterapia del alcohol, Bebedores problemáticos, Medicación dirigida Resumen: This study aimed to replicate and extend prior research showing that the targeted use of naltrexone is a useful strategy to reduce heavy drinking. We compared the effects of naltrexone with those of placebo in a sample of 163 individuals (58.3% male) whose goal was to reduce their drinking to safe limits. Link: ./index.php?lvl=notice_display&id=29497 [artículo] Targeted naltrexone for problem drinkers [texto impreso] / Henry R. Kranzler, Autor ; Howard Tennen, Autor ; Stephen Armeli, Autor . - 2022 . - pp. 350-357. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 4 (Agosto) . - pp. 350-357 Palabras clave: Naltrexona, Farmacoterapia del alcohol, Bebedores problemáticos, Medicación dirigida Resumen: This study aimed to replicate and extend prior research showing that the targeted use of naltrexone is a useful strategy to reduce heavy drinking. We compared the effects of naltrexone with those of placebo in a sample of 163 individuals (58.3% male) whose goal was to reduce their drinking to safe limits. Link: ./index.php?lvl=notice_display&id=29497

---

1 (1 - 3 / 3)